Stock Screener App

무료 -

1.03

1.90% -0.02

Bright Minds Biosciences Inc (DRUG)

개요 뉴스 가격 이력 토론 예측 주식 분할

Bright Minds Biosciences Inc 주식(DRUG)의 최신 뉴스

Japan Display Inc. (OTCMKTS:JNNDF) Short Interest Update - Defense World

Bright Minds Biosciences Inc. (NASDAQ:DRUG) Short Interest Update - Defense World

Novak & Powell Financial Services Inc. Invests $652000 in SPDR S&P International Dividend ETF (NYSEARCA:DWX) - Defense World

New Study Reveals Psychedelic Drugs Can Be Almost as Life-Changing as Near-Death Experiences - The Globe and Mail

The Globe and Mail

Bright Minds Biosciences Announces Upcoming AGM - TipRanks.com - TipRanks

Bright Minds Biosciences Reports Financial Downturn - TipRanks.com - TipRanks

ILMN: 3 Biotech Stocks to Buy in 2024 - StockNews.com

Psyched: LSD, Psilocybin As Breakthrough Therapies, $14M Fed Grant For Ibogaine, Indiana's Research And M - Benzinga

Mind Medicine sends psychedelic stocks higher on LSD drug - Seeking Alpha

Envestnet Asset Management Inc. Increases Stock Position in Ball Co. (NYSE:BALL) - American Banking and Market News

American Banking and Market News

4 Best Psychedelic Stocks In Canada to Examine in June 2024 - Wealth Awesome

Short sales on the TSX: What bearish investors are betting against - The Globe and Mail

The Globe and Mail

Psyched: $100M For MDMA Therapy, VA Funds, 2024 Watchlist, Reform Updates And More - ATAI Life Sciences ... - Benzinga

Psyched: DEA's Denial Overruled, Fed Psychedelics Change, Psilocybin For Depression, States Reform & More - Benzinga

Psyched: Steve Cohen's New Biopharma Bet, California Gov. Authorizes Medical Psychedelics & More - ATAI L - Benzinga

Psyched: Steve Cohen Goes Big On Cybin, Fed Intervention On Psilocybin, Ketamine Insurance And More - ATAI Life ... - Benzinga

PurMinds Appoints Leading Drug Designer to Scientific Advisory Board - Microdose Psychedelic Insights

Microdose Psychedelic Insights

Serotonin agonist BMB-101 found safe, well-tolerated in healthy... - Dravet Syndrome News

Dravet Syndrome News

Psyched: Portugal Decriminalizes Synthetic Drugs, Anorexia And Psilocybin, LSD Microdosing, California & More - Markets Insider

Markets Insider

How Enthea is Revolutionizing Psychedelic-Assisted Therapy Accessibility feat. Sherry Rais - Psychedelic Spotlight

Psychedelic Spotlight

Bright Minds completes first-in-human study of BMB-101 - Clinical Trials Arena

Clinical Trials Arena

Bright Minds Biosciences Announces Positive Topline Data for its First-in-Human Phase 1 Study of Lead Compound ... - GlobeNewswire

Bright Minds Announces Effective Date of Share Consolidation - GlobeNewswire

Bright Minds Announces Proposed Share Consolidation - Yahoo Finance

Perfect time to invest in psychedelics before Big Pharma makes its move: VC fund manager - Proactive Investors UK

Proactive Investors UK

Psychedelics Stocks to Watch | INN - Investing News Network

Investing News Network

Who's Suing Whom: April 19, 2023 - Business in Vancouver

Business in Vancouver

Bright Minds Biosciences to Present at the 20th International Meeting of the International Society for Serotonin Research - Psychedelic Alpha

Psychedelic Alpha

Bright Minds' Dravet syndrome treatment shows promise in trial |... - Dravet Syndrome News

Dravet Syndrome News

PsychedelicScape 2023: Psychedelic Companies Building the Future - NuWire Investor

NuWire Investor

Most Funded Psychedelic Companies 2023 - NuWire Investor

NuWire Investor

Post-traumatic Stress Disorder Clinical Trials Pipeline Analysis: 25+ Companies are Working to Improve the Treatment ... - GlobeNewswire

Why Hill International Is Trading Higher By 15%; Here Are 30 Stocks Moving Premarket By Benzinga - Investing.com UK

Investing.com UK

Dow, S&P 500 Edge Lower Following Powell's Comments - Markets Insider

Markets Insider

Psychedelic Drug Therapy May Help Treat Alcohol Addiction - NYU Langone Health

NYU Langone Health

Psychedelic Bulletin #115 - Mydecine Looks Set to Shutter; MindMed Gains 'Meme Stock' Status; atai 'Streamlilnes ... - Psychedelic Alpha

Psychedelic Alpha

Bright Minds Biosciences Comments on Recent Trading Activity - GlobeNewswire

Psychedelic Therapeutics Market worth $ 8.31 billion by 2028 - Exclusive Report by InsightAce Analytic - PR Newswire

BioSpace Movers & Shakers: Evommune, Maravai, Aptose & More - BioSpace

The Four Psychedelics ETFs Capturing Investor Attention - Psychedelic Spotlight

Psychedelic Spotlight

Cluster Headache Syndrome (Cluster Headache) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type ... - GlobalData

Consolidating Plant Medicine, Permaculture and Indigenous Wisdom With Colette Condorcita, Decriminalize ... - Psychedelic Spotlight

Psychedelic Spotlight

Elon Musk Tweet Excites Psychedelic CEOs - Psychedelic Spotlight

Psychedelic Spotlight

Psychedelic Sector Overview - Psychedelic Alpha

Psychedelic Alpha

Kevin O'Leary Predicts These 3 Psychedelic Companies Will Merge - Psychedelic Spotlight

Psychedelic Spotlight

Cluster Headache Syndrome (Cluster Headache) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type ... - GlobalData

Psychedelic Bulletin: MINDCURE - A Canary in the Psychedelic Coal Mine? - Psychedelic Alpha

Psychedelic Alpha

Bright Minds Biosciences Announces Successful Completion of 28-Day Toxicology Studies and Advancement to First ... - Yahoo Finance

Psychedelic Therapy and Suicide: A Myth Busted? - Medscape

Bright Minds Biosciences to Present at the H.C. Wainwright Bioconnect Conference - Yahoo Finance

$85.02

1.81%

$25.78

1.57%

$159.38

1.97%

$157.30

1.93%

$88.44

3.95%

$378.30

2.25%

야후에서 열기 | 구글에서 열기 | 핀비즈에서 열기